McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
via Google News
The Latest on: Drug discovery
- Secarna Pharmaceuticals announces the acquisition of LNAplus(TM) based antisense drug candidates by Lipigon Pharmaceuticalson March 23, 2020 at 12:24 am
The antisense oligonucleotide candidates targeting the ANGPTL gene family for the treatment of cardiovascular and metabolic diseases were previously generated by Secarna and Lipigon under a target ...
- New understanding of immune modulator interleukin-2 guides drug discoveryon March 22, 2020 at 5:08 pm
The new study provides a mechanistic explanation for these effects that can guide further drug discovery efforts. "The details of the mechanism we present offer a direct blueprint for drug discovery," ...
- Recent developments in the detection process and drug discoveryon March 21, 2020 at 2:07 pm
In the current pandemic situation discovering new vaccines against coronavirus is not a suitable option, as it is a prolonged process. Favipiravir is a type of drug that blocks RNA-dependent RNA ...
- Might The Experimental Drug Remdesivir Work Against COVID-19?on March 21, 2020 at 6:20 am
"For patients or [the] general public, it is understandable that hope is important," says Ding, who also directs the Global Health Drug Discovery Institute. "But such hope or expectation needs to be ...
- PolarisQB and Fujitsu announce pioneering drug discovery platform to speed up the process of bringing new drugs to marketon March 19, 2020 at 3:36 pm
Polarisqb has partnered with Fujitsu to create a ground-breaking drug discovery platform combining quantum-inspired technology, machine learning, hybrid quantum mechanics and molecular mechanics ...
- Drug Discovery Technologies Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025on March 18, 2020 at 1:25 am
New York, March 18, 2020: The global Drug Discovery Technologies market is segregated on the basis of Technology as High Throughput Screening (HTS), Genomics, Biochips, Bioanalytical Instruments, ...
- Computer-Aided Drug Discovery Market 2020-2024 | Growing Need for Reducing Healthcare Costs to Boost Growth | Technavioon March 13, 2020 at 6:30 pm
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the computer-aided drug discovery market and it is poised to grow by USD 21.75 bn during 2020-2024, progressing at a CAGR of almost 3% during the ...
- Schrödinger Taps Google Cloud HPC Solution to Bolster Drug Discoveryon March 13, 2020 at 9:04 am
Schrödinger has entered into a three-year agreement with Google Cloud to substantially increase the speed and capacity of its physics-based computational platform for drug discovery. We’re excited to ...
- Running Your Pharma Company Out Of A Starbucks: Drug Discovery Moves To The Cloudon March 13, 2020 at 5:13 am
Fifteen years and $2.5 billion dollars is too much to get a drug to market that no one can afford. Strateos' solution: put big pharma in the cloud, and make drug discovery possible from a coffee shop.
- A Curiously Linear Path to Academic Drug Discoveryon March 12, 2020 at 9:04 am
Find more information on the Altmetric Attention Score and how the score is calculated. Medicinal chemistry graduate students interested in drug discovery usually consider only two career paths: ...
via Bing News